HomeInsightsStock Comparison

Indoco Remedies Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Indoco Remedies Ltd vs Sun Pharmaceuticals Industries Ltd Stock Comparison

Last Updated on: May 25, 2025

Key Highlights

  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 243 as of 23 May 15:30.
  • The P/E Ratio of Indoco Remedies Ltd changed from 79.9 on March 2020 to 30.8 on March 2024 . This represents a CAGR of -17.36% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Indoco Remedies Ltd changed from ₹ 1929 crore on March 2020 to ₹ 3027 crore on March 2024 . This represents a CAGR of 9.43% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Indoco Remedies Ltd for the Mar '25 is ₹ 392.23 crore as compare to the Dec '24 revenue of ₹ 412.39 crore. This represent the decline of -4.89% The revenue of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 13571 crore as compare to the Dec '24 revenue of ₹ 14141 crore. This represent the decline of -4.03%.
  • The ebitda of Indoco Remedies Ltd for the Mar '25 is ₹ 1.24 crore as compare to the Dec '24 ebitda of ₹ 13.87 crore. This represent the decline of -91.06% The ebitda of Sun Pharmaceutical Industries Ltd for the Mar '25 is ₹ 3967 crore as compare to the Dec '24 ebitda of ₹ 4158 crore. This represent the decline of -4.6%.
  • The net profit of Indoco Remedies Ltd changed from ₹ 24.18 crore to ₹ -41.34 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2160 crore over 8 quarters. This represents a CAGR of 3.60% .
  • The Dividend Payout of Indoco Remedies Ltd changed from 11.4 % on March 2020 to 11.86 % on March 2024 . This represents a CAGR of 0.79% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Indoco Remedies Ltd News Hub

News

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug

Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also use...

Read more

23 May 2025 11:34

News

Indoco Remedies receives USFDA final approval for Allopurinol Tablets

 Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Compa...

Read more

23 May 2025 11:50

News

Board of Indoco Remedies recommends final dividend

Indoco Remedies announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:09

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 15:46

News

Indoco Remedies Ltd leads losers in 'B' group

Premier Energies Ltd, Shiva Texyarn Ltd, Waaree Energies Ltd and Khandwala Securities Ltd ...

Read more

22 Jan 2025 14:45

News

Indoco Remedies slides on recording dismal Q3 numbers in FY25

Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61%...

Read more

21 Jan 2025 12:53

Sun Pharmaceutical Industries Ltd News Hub

News

Board of Sun Pharmaceutical Industries appoints director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved...

Read more

23 May 2025 11:13

News

Sun Pharmaceutical Industries announces cessation of director

The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has noted th...

Read more

23 May 2025 11:14

News

Sun Pharma drops after Q4 PAT slides 19% YoY to Rs 2,1450 cr

Profit before tax (PBT) jumped 15.6% YoY to Rs 3,254.35 crore in Q4 FY25. During the quart...

Read more

23 May 2025 13:48

News

Sun Pharmaceuticals Industries AGM scheduled

Sun Pharmaceuticals Industries announced that the 33th Annual General Meeting(AGM) of the ...

Read more

23 May 2025 15:37

News

Board of Sun Pharmaceuticals Industries recommends final dividend

Sun Pharmaceuticals Industries announced that the Board of Directors of the Company at its...

Read more

22 May 2025 20:47

News

Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%

Sun Pharmaceutical Industries Ltd rose 2.83% today to trade at Rs 1733.95. The BSE Healthc...

Read more

13 May 2025 09:30

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Indoco Remedies Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Indoco Remedies Ltd is 2,241 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 403,868 Cr

What are the key factors driving the stock performance of Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd?

As of May 25, 2025, the Indoco Remedies Ltd stock price is INR ₹243.0. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1683.25.

How do dividend payouts of Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Indoco Remedies Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions